Diluted EPS came in at $-23.30, missed the $-19.40 consensus by $3.90.
Trailing eight quarters through Q1 2025
Common questions about Briacell Therapeutics Corp.'s Q1 2025 earnings report.
Briacell Therapeutics Corp. (BCTX) reported Q1 2025 earnings on March 12, 2025 before market open.
Briacell Therapeutics Corp. reported diluted EPS of $-23.30 for Q1 2025.
EPS missed the consensus estimate of $-19.40 by $3.90.
You can read the 10-Q periodic report (0001493152-25-010052) directly on SEC EDGAR. The filing index links above go to sec.gov.